Gonadotropin therapy in idiopathic hypogonadal non-obstructive azoospermia (APHRODITE Groups 3–4): a multicenter randomized controlled trial - Top-Institutions - MDSpire

Gonadotropin therapy in idiopathic hypogonadal non-obstructive azoospermia (APHRODITE Groups 3–4): a multicenter randomized controlled trial

  • By

  • Vipin Chandra

  • Sandro C. Esteves

  • Shashank Sanagoudar

  • July 9, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    NewYork-Presbyterian Hospital/Weill Cornell Medicine
    NewYork-Presbyterian Hospital/Weill Cornell Medicine

    New York, New York

    Key Differentiators

    • Male Reproductive Medicine
    • Reproductive Genomics

  • #2

    Androfert – Andrology and Human Reproduction Clinic
    Androfert – Andrology and Human Reproduction Clinic

    Campinas, São Paulo

    Key Differentiators

    • Andrology
    • Human Reproduction

Original Source(s)

Gonadotropin therapy in idiopathic hypogonadal non-obstructive azoospermia (APHRODITE Groups 3–4): a multicenter randomized controlled trial

  • by Vipin Chandra, Sandro C. Esteves, Shashank Sanagoudar

  • July 9, 2026

Related Content

Associations of parathyroid hormone and atrial fibrillation: epidemiological insights from the LURIC study

Macrophages in MASLD: from inflammatory and metabolic crosstalk to exercise intervention

Timing and dose of acupuncture as adjuncts to assisted reproduction: a meta-analysis and model-based network meta-analysis